Glenmark Pharmaceuticals (GLENMARK.NSE) null Earnings

30SepConfirmed
Dec 17
Mar 18
Jun 18
Sep 18
3.31
5.12
6.94
8.75

Details

Expected EPS
7.13
Actual EPS
8.75
Surprise EPS
1.62
Surprise Percent
+22.72%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 8.75 per share for .

0 Comments

Share your thoughts